Maravai LifeSciences Holdings Inc (MRVI) rating downgrades by Robert W. Baird

Anna Perez

Maravai LifeSciences Holdings Inc’s recent filing unveils that its Chief Executive Officer Brust Bernd acquired Company’s shares for reported $0.7 million on Nov 13 ’25. In the deal valued at $3.25 per share,216,212 shares were bought. As a result of this transaction, Brust Bernd now holds 466,771 shares worth roughly $1.56 million.

Then, Brust Bernd bought 157,201 shares, generating $509,331 in total proceeds. Upon buying the shares at $3.24, the Chief Executive Officer now owns 157,201 shares.

Before that, Brust Bernd bought 93,358 shares. Maravai LifeSciences Holdings Inc shares valued at $299,679 were divested by the Chief Executive Officer at a price of $3.21 per share. As a result of the transaction, Brust Bernd now holds 250,559 shares, worth roughly $0.84 million.

Robert W. Baird downgraded its Maravai LifeSciences Holdings Inc [MRVI] rating to a Neutral from a an Outperform in a research note published on February 26, 2025; the price target was decreased to $3 from $9. A number of analysts have revised their coverage, including Guggenheim’s analysts, who began to cover the stock in mid December with a ‘”a Neutral”‘ rating. Goldman also remained covering MRVI and has decreased its forecast on December 05, 2024 with a “Sell” recommendation from previously “Neutral” rating. Wolfe Research started covering the stock on November 14, 2024. It rated MRVI as “a Peer perform”.

Price Performance Review of MRVI

On Monday, Maravai LifeSciences Holdings Inc [NASDAQ:MRVI] saw its stock fall -8.24% to $3.34. Over the last five days, the stock has gained 7.74%. Maravai LifeSciences Holdings Inc shares have fallen nearly -40.67% since the year began. Nevertheless, the stocks have fallen -38.72% over the past one year. While a 52-week high of $6.21 was reached on 01/08/25, a 52-week low of $1.66 was recorded on 04/17/25.

Levels Of Support And Resistance For MRVI Stock

The 24-hour chart illustrates a support level at 3.21, which if violated will result in even more drops to 3.08. On the upside, there is a resistance level at 3.56. A further resistance level may holdings at 3.78.

How much short interest is there in Maravai LifeSciences Holdings Inc?

A steep rise in short interest was recorded in Maravai LifeSciences Holdings Inc stocks on 2025-10-31, dropping by -0.11 million shares to a total of 12.99 million shares. Yahoo Finance data shows the prior-month short interest on 2025-09-30 was 13.1 million shares. There was a decline of -0.84%, which implies that there is a negative sentiment for the stock.

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.